Evaluation of damaging effects of splicing mutations: validation of an in vitro method for diagnostic laboratories.

BACKGROUND Pre-mRNA splicing defects may have an important impact on clinical phenotype in several diseases, but often their pathogenic role is difficult to demonstrate. The aim of this study was to validate an in vitro method to assess the effects of putative splicing variants. MATERIALS AND METHODS We studied three novel variants in vitro using a novel minigene approach and compared results with in silico and ex vivo strategies from patient samples. RESULTS For the c.1146C>T variant in the LMNA gene, in vitro and ex vivo studies were concordant with the prediction obtained by in silico tools, confirming the loss of 13 bp at the end of exon 6. In the second case (c.1140+1G>A, SCN5A gene), in vitro experiments identified the insertion of 94 intronic bp in exon 9 as well as exon 9 skipping, but these results were not correctly predicted by ex vivo data and in silico tools. In the third case (c.1608+1C>T, LMNA gene) in vitro and ex vivo studies suggested the recognition of an exonic cryptic site leading to the loss of 29 bp in exon 9, not predicted by in silico analysis. CONCLUSION Our results revealed how in silico tools are often unreliable requiring "wet" RNA analysis. Since ex vivo studies are not always feasible, the use of an in vitro construct represents an efficient and useful method for the evaluation of damaging effects of unknown splicing variants, especially in diagnostic laboratories.

[1]  P. Tarpey,et al.  Automated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11–17 distinct from the GAP related domain , 2004, Journal of Medical Genetics.

[2]  G. Novelli,et al.  The strange case of the "lumper" lamin A/C gene and human premature ageing. , 2003, Trends in molecular medicine.

[3]  Guey-Shin Wang,et al.  Splicing in disease: disruption of the splicing code and the decoding machinery , 2007, Nature Reviews Genetics.

[4]  L. Maquat.  Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics , 2004, Nature Reviews Molecular Cell Biology.

[5]  S. Stamm,et al.  Alternative splicing and disease. , 2009, Biochimica et biophysica acta.

[6]  P. Schwartz,et al.  A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. , 2009, Heart rhythm.

[7]  X. Estivill,et al.  Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients , 2003, Journal of medical genetics.

[8]  V. Pertegato,et al.  Is CFTR 621+3 A>G a cystic fibrosis causing mutation? , 2010, Journal of Human Genetics.

[9]  Dominique Stoppa-Lyonnet,et al.  Evaluation of in silico splice tools for decision‐making in molecular diagnosis , 2008, Human mutation.

[10]  T. Frebourg,et al.  Use of splicing reporter minigene assay to evaluate the effect on splicing of unclassified genetic variants. , 2010, Methods in molecular biology.

[11]  L. Corcos,et al.  Splicing defects in the CFTR gene: minigene analysis of two mutations, 1811+1G>C and 1898+3A>G. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[12]  D. Niederacher,et al.  Diagnostics of pathogenic splicing mutations: does bioinformatics cover all bases? , 2008, Frontiers in bioscience : a journal and virtual library.

[13]  E. Bertini,et al.  Phenotypic clustering of lamin A/C mutations in neuromuscular patients , 2007, Neurology.

[14]  D. Baralle,et al.  Missed threads , 2009, EMBO reports.

[15]  J. Tazi,et al.  A large fraction of unclassified variants of the mismatch repair genes MLH1 and MSH2 is associated with splicing defects , 2008, Human mutation.